Interactions of dynorphin A and related peptides with cardiac ouabain binding sites

Journal of Molecular and Cellular Cardiology

Volumn 28, Issue 3, 1996, Pages 615-621

  Dumont, Michel ^a   Lemaire, Simon ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Dynorphin A; Heart; Na+ K+ ATPase; Ouabain receptor

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); DELTA OPIATE RECEPTOR; DYNORPHIN A; KAPPA OPIATE RECEPTOR; LEUCINE ENKEPHALIN; MU OPIATE RECEPTOR; NORADRENALIN; OPIATE AGONIST; OUABAIN;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; ENZYME INHIBITION; HEART FUNCTION; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SARCOLEMMA; SCATCHARD PLOT; SYNAPTOSOME;

ANIMALIA; STROPHANTHUS GRATUS;

EID: 0029875345     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1996.0057     Document Type: Article

References (31)

1. 3H]norepinephrine by rat heart slices. J Pharmacol Exp Ther 165: 181-189.
2. +-ATPase subunit isoforms at mRNA and protein levels in rat myocardium. J Mol Cell Cardiol 26: 591-600.
3. +)-ATPase activity in rat cardiac hypertrophy. Expression of the neonatal forms. J Biol Chem 261: 185-189.
4. CHARLEMAGNE D, ORLOWSKI J, OLIVIERO P, RANNOU F, BEUVE CS, SWYNGHEDAUW B, LANE LK, 1994. Alteration of Na-K-ATPase subunit mRNA and protein levels in hypertrophied rat heart. J Biol Chem 269: 1541-1547.
5. CHAVKIN C, JAMES IF, GOLDSTEIN A, 1982. Dynorphin is a specific endogenous ligand for the κ-opioid receptor. Science 215: 413-415.
6. DUMONT M, SABOURIN L, LEMAIRE S, 1990. Alterations of heart dynorphin A in the development of spontaneously hypertensive rats. Neuropeptides 15: 43-48.
7. 3H]dynorphin A-(1-13) binding sites in the rat heart. J Mol Cell Cardiol 25: 983-991.
8. DUMONT M, LEMAIRE S, 1995. Inhibitory effects of dynorphin A on noradrenaline uptake by cardiac synaptosomal mitochondrial fractions. J Cardiovasc Pharmacol 25: 518-523.
9. +-ATPase α-subunit gene expression in hypertension. Science 241: 221-223.
10. IVERSEN LL, 1971. Role of transmitter uptake mechanism in synaptic neurotransmission. Br J Pharmacol 41: 571-591.
11. LEBEL D, POIRIER GG, BEAUDOIN AR, 1978. A convenient method for the ATPase assay. Anal Biochem 85: 86-89.
12. 3H]ouabain binding sites in sarcolemma prepared from hearts of spontaneously hypertensive rats. Hypertension 5: 682-688.
13. LELIEVRE LG, CHARLEMAGNE D, MOUAS C, SWYNGHEDAUW B, 1986. Respective involvements of high-and low-affinity digitalis receptors in the inotropic response of isolated rat heart ouabain. Biochem Pharmacol 35: 3449-3455.
14. LEMAIRE S, LAFRANCE L, DUMONT M, 1986. Synthesis and biological activity of dynorphin-(1-13) and analogs substituted in position 8 and 10. Int J Peptide Protein Res 27: 300-307.
15. LINGREL JB, 1992. NaK-ATPase: isoform structure, function and expression. J Bioenerg Biomembr 24: 263-270.
16. LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ, 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
17. MAEDA S, NAKAMAE J, INOKI R, 1987. Positive inotropic action of κ opiate agonists, ethylketocyclazocine and dynorphin-A-(1-13) in isolated rat atrium. Jap J Pharmacol 5: 125-128.
18. +-ATPase activity by dynorphin A and ethylketocyclazocine. Life Sci 42: 461-466.
19. MIR MA, MORGAN K, CHAPPELL S, LEWIS M, SPURLOCK G, COLLINS P, LEWIS M, SCANLON M, 1988. Calcium retention and increased vascular reactivity caused by a hypothalamic sodium transport inhibitor. Clin Sci 75: 197-202.
20. MORGAN K, LEWIS MD, SPURLOCK G, COLLINS PA, FOORD SM, SOUTHGATE K, SCANLON MF, MIR MA, 1985. Characterization and partial purification of the sodium-potassium-ATPase inhibitor released from cultured rat hypothalamic cells. J Biol Chem 260: 13595-13600.
21. RHO JH, NEWMAN B, ALEXANDER N, 1981. Altered in vitro uptake of norepinephrine by cardiovascular tissues of spontaneously hypertensive rats, part 2. Portalmesenteric veins and atria. Hypertension 3: 710-717.
22. ROLE LW, PERLMAN RL, 1983. Catecholamine uptake into isolated adrenal chromaffin cells: inhibition of uptake by acetylcholine. Neuroscience 10: 987-996.
23. SALT PJ, IVERSEN LL, 1973. Catecholamine uptake sites in the rat heart after 6-hydroxydopamine treatment and in a genetically hypertensive strain. Naunyn-Schmeideberg's Arch Pharmacol 279: 381-386.
24. +-ATPase. Biochim Biophys Acta 988: 185-220.
25. 1 antagonism. Reg Peptides 31: 1-10.
26. THORNHILL JA, POWELL-JONES K 1987. Vasoconstrictor effects of endogenous opioid peptides on thoracic aortae isolated from Sprague-Dawley rats. Can JPhysiol Pharmacol 65: Axxxiii.
27. 2+-dependent ATPase activities in bovine cardiac sarcolemma. Peptides 8: 709-713.
28. VENTURA C, BASTAGLI L, BERNARDI P, CALDARERA CM, GUARNIERI C, 1989. Opioid receptors in rat cardiac sarcolemma: effects of phenylephrine and isoproterenol. Biochim Biophys Acta 987: 69-74.
29. WEILER EWJ, GONICK HC, PRINS BA, PURDY RE, WEBER MA, 1994. Characterization of a low molecular weight Na-K-ATPase inhibitor of urinary origin. Am J Med Sci 307: 27-35.
30. WERDAN K WAGENKNECHT B, ZWISSLER B, BROWN L, KRAWIETZ W, ERDMAN E, 1984. Cardiac glycoside receptors in cultured heart cells II. Characterization of a high affinity and a low affinity binding site in heart muscle cells from neonatal rats. Biochem Pharmacol 33: 1873-1886.
31. WONG SC, INGENITO AJ, 1993. Opioid receptor function changes in isolated atria of the spontaneously hypertensive rat. Gen Pharmacol 24: 1483-1490.